The workforce training platform developer secured the cash in a series B2 round featuring HV Capital, taking its overall funding to over $130m.
Month: September 2021
PetMedix gets $37m series B treat
Kyoritsu Holding and Tencent were among the investors that backed the pet antibody therapeutics developer, a spinout of Wellcome Sanger Institute.
Shunzao cleans up with $50m round
Country Garden and Poly Group-backed Real Estate Industry Chain Empowerment Fund led a series B round for the vacuum cleaner producer that included Xiaomi.
Vahdam brews up series D funding
Urmin Group helped the tea provider raise $23.5m in a round that increased its overall funding to more than $39m.
Daily Deal Round Up: September 7, 2021
Channel Talk, Segari and Borneo are all among the companies that have raised corporate venture capital, while Tepco celebrated an exit with the acquisition of Me:New.
ICT injected with $40m in series C
SoftBank-backed cancer immunotherapy developer ICT has collected series C funding from CDH Investments’ CDH VGC unit.
Haoxinqing hauls in $31m in series C
TikTok owner ByteDance and Fosun Health backed the mental health service provider’s $31m series C round.
Rising Stars Q&A – Jay Crone & Jon Wolkin, Telus Ventures
Q&A with Jay Crone and Jon Wolkin, directors, Telus Ventures
H2O Hospitality drinks in $30m series C
Kakao Investment has led a series C round for the Samsung Ventures-backed automated accommodation provider.
Virtuos visualises $150m
Legend Capital-backed video game and 3D art developer Virtuos has collected $150m from Baring Private Equity Asia.
Delhivery picks up $76.4m series I parcel
Fresh off an investment from FedEx, the logistics provider disclosed a $76.4m investment for its latest round.
ShopUp scoops up $75m in series B
Prosus Ventures has joined existing backer Veon Ventures in a series B round for business commerce platform ShopUp.
Quantum Machines zaps $50m in series B
With its eye on the next generation of computing technology, the quantum technology developer has secured funding from Samsung.
RootPath zeroes in on $50m series B
Baidu’s corporate venturing arm has re-invested in the immunotherapy developer to help commercialise its pipeline.